-Noveome Biotherapeutics, Inc. and Walter Reed Army Institute of Research to Study Noveome's Lead Product Candidate ST266 in Traumatic Brain Injury

Press/Media

Period2 Feb 2021

Media coverage

1

Media coverage

  • Title-Noveome Biotherapeutics, Inc. and Walter Reed Army Institute of Research to Study Noveome's Lead Product Candidate ST266 in Traumatic Brain Injury
    Media name/outletENP Newswire
    Country/TerritoryUnited Kingdom
    Date2/02/21
    PersonsDebra Shear